
IDEXX Laboratories IDXX
$ 675.24
-2.1%
IDEXX Laboratories EBITDA per Share | IDXX
Annual EBITDA per Share IDEXX Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.7 | 15.3 | 14.6 | 12.1 | 12.2 | 9.26 | 7.44 | 6.61 | 5.65 | 4.77 | 4.07 | 3.19 | 3.02 | 2.86 | 2.5 | 4.33 | 3.84 | 3.68 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.7 | 2.5 | 7.45 |
Quarterly EBITDA per Share IDEXX Laboratories
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.1 | 6.39 | 5.03 | -1.77 K | 4.89 | 4.64 | 4.31 | -1.26 K | 4.11 | 3.19 | 3.96 | 21.7 K | 3.66 | 3.9 | 3.72 | -683 | 3.28 | 2.47 | 3.26 | -1.08 K | 2.97 | 3.34 | 3.19 | 2.52 | 2.3 | 2.55 | 1.96 | -655 | 1.88 | 2.16 | 1.79 | 1.34 | 2.07 | 1.91 | 1.53 | -393 | 1.38 | 1.63 | 1.28 | -237 | 1.2 | 1.38 | 1.03 | -44 | 0.98 | 1.13 | 0.94 | -0.64 | 0.88 | 0.96 | 1.62 | 0.57 | 1.51 | 1.73 | 1.37 | -390 | 1.38 | 1.61 | 1.32 | -81.5 | 1.2 | 1.45 | 1.13 | -591 | 1.06 | 1.34 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 21.7 K | -1.77 K | 222 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Medpace Holdings
MEDP
|
19.5 | $ 609.81 | -3.81 % | $ 17.6 B | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Surmodics
SRDX
|
0.22 | - | - | $ 608 M | ||
|
RadNet
RDNT
|
2.85 | $ 69.77 | 0.37 % | $ 5.25 B | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Psychemedics Corporation
PMD
|
-0.14 | - | -1.84 % | $ 15.3 M | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
-2.94 | $ 7.55 | -9.1 % | $ 57 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
Agilent Technologies
A
|
6.22 | $ 169.82 | -3.21 % | $ 48.2 B | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 314.38 | -4.13 % | $ 15.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 257.78 | -0.4 % | $ 28.6 B | ||
|
Danaher Corporation
DHR
|
7.63 | $ 220.3 | -3.19 % | $ 157 B | ||
|
DexCom
DXCM
|
2.98 | $ 79.02 | -1.46 % | $ 30.8 B | ||
|
Anixa Biosciences
ANIX
|
-361 | $ 2.44 | -6.15 % | $ 79.2 K | ||
|
Celcuity
CELC
|
-3.68 | $ 53.32 | -5.31 % | $ 2.49 B | ||
|
Guardant Health
GH
|
-3.17 | $ 145.9 | 0.21 % | $ 18.3 B | ||
|
BioNano Genomics
BNGO
|
-4.37 | $ 0.82 | -7.56 % | $ 4.46 M | ||
|
Bioventus
BVS
|
1.52 | $ 9.89 | -0.65 % | $ 659 M | ||
|
IQVIA Holdings
IQV
|
19.4 | $ 245.67 | -1.92 % | $ 42.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 367.68 | -0.44 % | $ 30.6 B | ||
|
Castle Biosciences
CSTL
|
-0.07 | $ 32.69 | -2.14 % | $ 948 M | ||
|
Mettler-Toledo International
MTD
|
2.48 | $ 1 667.59 | -2.3 % | $ 34.4 B | ||
|
Illumina
ILMN
|
6.95 | $ 192.79 | -3.92 % | $ 29.9 B | ||
|
Natera
NTRA
|
-1.96 | $ 273.11 | -5.8 % | $ 37.3 B | ||
|
Koninklijke Philips N.V.
PHG
|
2.69 | $ 28.63 | -2.22 % | $ 27.1 B | ||
|
Fulgent Genetics
FLGT
|
-2.18 | $ 24.03 | -3.03 % | $ 740 M | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 69.9 | -2.81 % | $ 3.72 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Biomerica
BMRA
|
-1.8 | $ 1.09 | -0.46 % | $ 3.18 M | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 4.4 | -4.35 % | $ 19.5 M | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 102.12 | 0.01 % | $ 6.89 B | ||
|
Senseonics Holdings
SENS
|
-1.6 | $ 8.03 | -9.88 % | $ 335 M | ||
|
Sotera Health Company
SHC
|
0.33 | $ 15.92 | -1.82 % | $ 4.52 B | ||
|
ICON Public Limited Company
ICLR
|
10.5 | $ 186.79 | -1.88 % | $ 14.6 B | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 0.13 | -22.11 % | $ 173 K | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
23.3 | $ 668.26 | -2.95 % | $ 252 B | ||
|
DarioHealth Corp.
DRIO
|
-9.13 | $ 1.31 | -9.02 % | $ 5.22 M | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 5.47 | -1.26 % | $ 507 M | ||
|
Precipio
PRPO
|
0.03 | $ 17.46 | -5.6 % | $ 28 M | ||
|
ENDRA Life Sciences
NDRA
|
-1.11 | $ 3.58 | -3.38 % | $ 4.74 M | ||
|
QIAGEN N.V.
QGEN
|
3.04 | $ 49.28 | -0.72 % | $ 10.7 B | ||
|
NeoGenomics
NEO
|
-0.62 | $ 14.8 | -1.95 % | $ 1.9 B | ||
|
OPKO Health
OPK
|
-0.03 | $ 1.58 | -2.17 % | $ 1.19 B | ||
|
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.64 | -7.1 % | $ 492 M | ||
|
Neogen Corporation
NEOG
|
0.44 | $ 10.45 | -3.73 % | $ 2.27 B | ||
|
Personalis
PSNL
|
-0.87 | $ 14.29 | -2.96 % | $ 1.28 B |